Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
Clinical trial NCT07538128 · RECRUITING
Trial details
- NCT number
- NCT07538128
- Sponsor
- Huashan Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-09
- Primary completion
- 2026-11-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.